i got the info off BLT's London investor update from Oct. They listed near term news flow - see below. note tacere deal not listed! it's behind schedule but that's bio - some good stuff not far off
"well for what it's worth - the recent intersuisse london
update (Oct) had the following near term news flow items listed:
Q407 - Graham 099 patent USPTO
Q407 - Nucleonics litigation resolution
Q407/Q108 - IND for HIV T cell to be filed
Q108 - HIV stem cell prelim findings
Q208 - PI trial start HIV T cell
I think having a core group of patient investors is proving to be an asset to BLT as they negotiate the biotech obstacle course.
hopefully santa will bring us something for chrissy"
- Forums
- ASX - By Stock
- BLT
- oversold
oversold, page-7
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BLT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online